Products

Active Pharmaceutical Ingredients

No. PRODUCT STANDARDS END USE CAS
1 CILNIDIPINE JP/IH ANTI-HYPERTENSIVE 132203-70-4
2 BENIDIPINE HCl JP/IH ANTI-HYPERTENSIVE 91599-74-5
3 AZELNIDIPINE JP/IP/IH ANTI-HYPERTENSIVE 123524-52-7
4 IRON SUCROSE IH HAEMATINIC 8047-67-4
5 TORSEMIDE IP/USP/BP DIURECTIC 56211-40-6
6 FEBANTEL IP/EP/BP ANTHELMINTIC 58306-30-2
7 LEVOSULPIRIDE IH NEUROLEPTIC 23672-07-3
8 TAMSULOSIN HCl IP/BP/USP DIFFICULT URINATION 106463-17-6
9 FINASTERIDE IP/USP/EP DIFFICULT URINATION 98319-26-7
10 DUTASTERIDE IP/USP DIFFICULT URINATION 164656-23-9
11 LAFUTIDINE IH ANTI SECRETORY 118288-08-7
12 PRAZIQUANTEL IP/USP/BP/EP ANTHELMINTIC 55268-74-1
13 CILOSTAZOL USP ANTI-HYPERTENSIVE 73963-72-1
14 LORNOXICAM IH ARTHRITIS 70374-39-9
15 FEBUXOSTATE IH GOUT 144060-53-7
16 DAPOXETINE HCl IP/IH PREMATURE EJACULATION 129938-20-1
17 DOXOFYLLIN IP ASTHMA 69975-86-6
18 BOSENTAN MONOHYDRATE IH ANTI HYPERTENSIVE 157212-55-0
19 BUPROPION HCl USP SMOKING CESSATION 31677-93-7
20 NEPAFENAC IH OPHTHALMIC NSAID 78281-72-8
21 CALCITRIOL IP VITAMINE D ANALOGUE 32222-06-3
22 VINPOCETIN EP NEUROPROTECTIVE 42971-09-5
23 LOTEPREDNOL ETABONATE IH OPHTHALMIC STEROID 82034-46-6
24 ROSUVASTATIN CALCIUM IP/EP LIPID LOWERING AGENT 147098-20-2
  UNDER DEVELOPMENT      
25 TENELIGLIPTIN HBr IH ANTI DIABETIC 906093-29-6
26 AZILSARTAN KA MEDOXOMIL IH ANTI HYPERTENSIVE 863031-24-7
27 DACLATASVIR DIHCl IH HEPATITIS C 1009119-65-6

API Intermediates

Sr. No. Intermediates CAS END USE
1 Ethyl-2-ethoxy-1-((2'-(N'-hydroxycarbamimidoyl) biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7- carboxylate 1397836-41-7 Azilsartan Ka Medoxomil
2 Ethyl-2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate 147403-52-9
3 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4yl)methyl)-1H-benzo[d]imidazole-7-carboxylicacid [AZILSARTAN BASE] 147403-03-0
4 (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate[AZILSARTAN MEDOXOMIL] 863031-21-4
5 2-Cyanoacetic acid-1-(diphenylmethyl)-3-azetidinyl ester 116574-14-2 Azelnidipine
6 Isopropyl-2-(3-nitrobenzylidene)acetoacetate 39562-25-9
7 3-Amino-3-iminopropanoic acid-1-(diphenylmethyl)-3-azetidinyl ester acetate 170749-59-4
8 4,4’-Bis(2-bromoacetyl)biphenyl 4072-67-7 Daclatasvir
9 5,5’-[1,1’-biphenyl]-4,4’-diylbis[2-(2S)-2-pyrrolidinylhydrochloride (1:4) 1009119-83-8
10 1-(3-Methyl-1-phenyl-5-pyrazolyl)piperazine 401566-79-8 Teneligliptin
11 1-(3-Methyl-1-phenyl-5-pyrazolyl)piperazine Acetate Salt 906093-30-9
12 2-methoxyethyl-2-(3-nitrobenzyledene) Acetoacetate 39562-22-6 Cilnidipine
13 2-methoxy-N-[2-nitro-5-(phenylthio)phenyl] Acetamide 63470-85-9 Febantel
14 Methyl-6-chloro-4-hydroxy-2-methyl-2H-thieno[2,3 e][1,2] thiazine-3- carboxylate-1,1-dioxide 70415-50-8 Lornoxicam
15 3-chloro-2-bromo propiophenone 34911-51-8 Bupropione
16 6 2-(3-formyl-4-hydroxyphenyl)-4-methyl-5-Thiazolecarboxylic acid ethyl ester 161798-01-2 Febuxostat
Products protected by valid patents are not offered for sale in countries where the sale of such products constitute a patent infringement.